[Form 4] iRhythm Technologies, Inc Insider Trading Activity
Shrishrimal Sumi, EVP and Chief Risk Officer of iRhythm Technologies (IRTC), reported a sale of company stock. The Form 4 shows a single non-derivative disposition of 653 shares of common stock on 08/22/2025 at a price of $167.12 per share, leaving the reporting person with 34,032 shares beneficially owned.
The filing states the sale was executed pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 23, 2025. The Form 4 was filed by one reporting person and signed by an attorney-in-fact.
Shrishrimal Sumi, EVP e Chief Risk Officer di iRhythm Technologies (IRTC), ha comunicato la vendita di azioni della societ脿. Il Modulo 4 indica una singola cessione non derivativa di 653 azioni di azioni ordinarie il 22/08/2025 a un prezzo di $167,12 per azione, lasciando al dichiarante un totale di 34.032 azioni di propriet脿 beneficiaria.
La dichiarazione specifica che la vendita 猫 stata eseguita in conformit脿 a un piano di trading Rule 10b5-1 istituito dal dichiarante il 23 maggio 2025. Il Modulo 4 猫 stato presentato da un solo dichiarante e firmato da un procuratore.
Shrishrimal Sumi, EVP y Chief Risk Officer de iRhythm Technologies (IRTC), inform贸 la venta de acciones de la compa帽铆a. El Formulario 4 muestra una 煤nica disposici贸n no derivada de 653 acciones ordinarias el 22/08/2025 a un precio de $167.12 por acci贸n, dejando al informante con 34,032 acciones en propiedad beneficiaria.
La presentaci贸n indica que la venta se ejecut贸 conforme a un plan de negociaci贸n Rule 10b5-1 establecido por el informante el 23 de mayo de 2025. El Formulario 4 fue presentado por una sola persona informante y firmado por un apoderado.
iRhythm Technologies (IRTC)鞚� EVP 瓴� 斓滉碃鞙勴棙甏�毽眳鞛勳瀽(CRO)鞚� Shrishrimal Sumi臧� 須岇偓 欤检嫕鞚� 毵り皝頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 653欤�鞚� 氤错喌欤检棎 雽�頃� 雼澕 牍勴寣靸� 觳橂秳鞚� 2025-08-22鞐� 欤茧嫻 $167.12鞐� 鞚措（鞏挫鞙茧┌, 氤搓碃鞛愲姅 齑� 34,032欤�鞚� 鞁れ 氤挫湢毳� 鞙犾頃橂姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
鞁犼碃靹滌棎電� 頃措嫻 毵り皝鞚� 氤搓碃鞛愱皜 2025雲� 5鞗� 23鞚�鞐� 靹れ爼頃� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. Form 4電� 頃� 氇呾潣 鞁犼碃鞚胳棎 鞚橅暣 鞝滌稖霅橃棃瓿� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Shrishrimal Sumi, EVP et Chief Risk Officer d'iRhythm Technologies (IRTC), a signal茅 la vente d'actions de la soci茅t茅. Le formulaire 4 indique une seule cession non d茅riv茅e de 653 actions ordinaires le 22/08/2025 au prix de 167,12 $ par action, laissant le d茅clarant avec 34 032 actions en propri茅t茅 b茅n茅ficiaire.
Le d茅p么t pr茅cise que la vente a 茅t茅 ex茅cut茅e conform茅ment 脿 un plan de n茅gociation Rule 10b5-1 茅tabli par le d茅clarant le 23 mai 2025. Le formulaire 4 a 茅t茅 d茅pos茅 par une seule personne d茅clarante et sign茅 par un mandataire.
Shrishrimal Sumi, EVP und Chief Risk Officer von iRhythm Technologies (IRTC), meldete den Verkauf von Unternehmensaktien. Das Formular 4 weist eine einzelne nicht-derivative Ver盲u脽erung von 653 Aktien Stammaktien am 22.08.2025 zu einem Preis von $167,12 pro Aktie aus, wodurch die meldende Person weiterhin 34.032 Aktien wirtschaftlich besitzt.
In der Meldung hei脽t es, der Verkauf sei gem盲脽 einem Rule 10b5-1-Handelsplan ausgef眉hrt worden, den die meldende Person am 23. Mai 2025 eingerichtet hatte. Das Formular 4 wurde von einer meldenden Person eingereicht und von einem Bevollm盲chtigten unterschrieben.
- None.
- None.
Insights
TL;DR: Officer sale disclosed under a documented 10b5-1 plan; filing shows compliance and routine insider activity.
The Form 4 records a controlled disposition of 653 shares by Shrishrimal Sumi, EVP and Chief Risk Officer, at $167.12 per share on 08/22/2025. The seller used a Rule 10b5-1 plan established on May 23, 2025, which is a common mechanism to mitigate concerns about trading on material non-public information. The filing includes the remaining beneficial ownership (34,032 shares) and is signed by an attorney-in-fact, indicating procedural completion of required disclosures. From a governance perspective, this is a standard, documented insider transaction rather than an unexplained block sale.
TL;DR: Transaction is transparent and documented; no additional material details provided to suggest market-moving significance.
The report details a single non-derivative sale (code S) of 653 common shares on 08/22/2025 at $167.12, with 34,032 shares held after the sale. The explicit note that the sale was effected pursuant to a 10b5-1 trading plan (established 05/23/2025) clarifies the trading context. The filing does not disclose multiple transactions, derivative activity, or other changes in ownership that would indicate a material shift in insider position. Based solely on the disclosed facts, this appears to be routine insider selling under a pre-established plan.
Shrishrimal Sumi, EVP e Chief Risk Officer di iRhythm Technologies (IRTC), ha comunicato la vendita di azioni della societ脿. Il Modulo 4 indica una singola cessione non derivativa di 653 azioni di azioni ordinarie il 22/08/2025 a un prezzo di $167,12 per azione, lasciando al dichiarante un totale di 34.032 azioni di propriet脿 beneficiaria.
La dichiarazione specifica che la vendita 猫 stata eseguita in conformit脿 a un piano di trading Rule 10b5-1 istituito dal dichiarante il 23 maggio 2025. Il Modulo 4 猫 stato presentato da un solo dichiarante e firmato da un procuratore.
Shrishrimal Sumi, EVP y Chief Risk Officer de iRhythm Technologies (IRTC), inform贸 la venta de acciones de la compa帽铆a. El Formulario 4 muestra una 煤nica disposici贸n no derivada de 653 acciones ordinarias el 22/08/2025 a un precio de $167.12 por acci贸n, dejando al informante con 34,032 acciones en propiedad beneficiaria.
La presentaci贸n indica que la venta se ejecut贸 conforme a un plan de negociaci贸n Rule 10b5-1 establecido por el informante el 23 de mayo de 2025. El Formulario 4 fue presentado por una sola persona informante y firmado por un apoderado.
iRhythm Technologies (IRTC)鞚� EVP 瓴� 斓滉碃鞙勴棙甏�毽眳鞛勳瀽(CRO)鞚� Shrishrimal Sumi臧� 須岇偓 欤检嫕鞚� 毵り皝頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 653欤�鞚� 氤错喌欤检棎 雽�頃� 雼澕 牍勴寣靸� 觳橂秳鞚� 2025-08-22鞐� 欤茧嫻 $167.12鞐� 鞚措（鞏挫鞙茧┌, 氤搓碃鞛愲姅 齑� 34,032欤�鞚� 鞁れ 氤挫湢毳� 鞙犾頃橂姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
鞁犼碃靹滌棎電� 頃措嫻 毵り皝鞚� 氤搓碃鞛愱皜 2025雲� 5鞗� 23鞚�鞐� 靹れ爼頃� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. Form 4電� 頃� 氇呾潣 鞁犼碃鞚胳棎 鞚橅暣 鞝滌稖霅橃棃瓿� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Shrishrimal Sumi, EVP et Chief Risk Officer d'iRhythm Technologies (IRTC), a signal茅 la vente d'actions de la soci茅t茅. Le formulaire 4 indique une seule cession non d茅riv茅e de 653 actions ordinaires le 22/08/2025 au prix de 167,12 $ par action, laissant le d茅clarant avec 34 032 actions en propri茅t茅 b茅n茅ficiaire.
Le d茅p么t pr茅cise que la vente a 茅t茅 ex茅cut茅e conform茅ment 脿 un plan de n茅gociation Rule 10b5-1 茅tabli par le d茅clarant le 23 mai 2025. Le formulaire 4 a 茅t茅 d茅pos茅 par une seule personne d茅clarante et sign茅 par un mandataire.
Shrishrimal Sumi, EVP und Chief Risk Officer von iRhythm Technologies (IRTC), meldete den Verkauf von Unternehmensaktien. Das Formular 4 weist eine einzelne nicht-derivative Ver盲u脽erung von 653 Aktien Stammaktien am 22.08.2025 zu einem Preis von $167,12 pro Aktie aus, wodurch die meldende Person weiterhin 34.032 Aktien wirtschaftlich besitzt.
In der Meldung hei脽t es, der Verkauf sei gem盲脽 einem Rule 10b5-1-Handelsplan ausgef眉hrt worden, den die meldende Person am 23. Mai 2025 eingerichtet hatte. Das Formular 4 wurde von einer meldenden Person eingereicht und von einem Bevollm盲chtigten unterschrieben.
